Melanoma

2 researchers across 1 institution

2 Researchers
1 Institutions
0 Grant PIs
0 High Impact

Research in melanoma focuses on understanding the development, progression, and treatment of this aggressive form of skin cancer. Investigations explore the molecular and cellular mechanisms that drive melanoma formation, including genetic mutations and epigenetic alterations. Studies examine the complex interplay between the immune system and melanoma, seeking to identify new targets for immunotherapy. Methodologies employed include advanced genomic sequencing, cell culture models, animal studies, and the analysis of patient data. The research also encompasses the development and testing of novel pharmacological agents and treatment strategies.

Given Arkansas's demographic profile and environmental factors, research into melanoma holds particular public health significance. Understanding the prevalence and risk factors for melanoma within the state informs targeted prevention efforts and early detection initiatives. The work contributes to the broader understanding of cancer burdens and the development of effective treatments that can benefit Arkansas residents.

This area of study is inherently interdisciplinary, connecting with research in cancer treatment and pharmacology, cancer-related molecular mechanisms, metabolomics, epigenetics, immune response, and microbial influences. Collaboration across institutions is essential for advancing knowledge and developing comprehensive approaches to combat melanoma.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Nathan L. Avaritt UAMS 7 206
Billie Heflin UAMS 4 64

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: MEDIUM

Global trajectory
1 works in 2031
-46.7% CAGR 2018–2031
Leadership concentration
7.1% held by global top 5 institutions
Fragmented HHI 31
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2031 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 1,888
  2. 2 Harvard University 1,460
  3. 3 Massachusetts General Hospital 1,277
  4. 4 Memorial Sloan Kettering Cancer Center 1,248
  5. 5 Dana-Farber Cancer Institute 944
Browse All 2 Researchers in Directory